Covered recipient · General Payments record
YARA GEORGE ABDOU
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$14,503.50
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,900.00 | 3 |
| Travel and Lodging | $900.85 | 3 |
| Food and Beverage | $255.48 | 3 |
| Education | $18.09 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TerSera Therapeutics LLC | $2,965.44 | 5 |
| Acerta Pharma LLC | $1,640.00 | 1 |
| PFIZER INC. | $1,405.14 | 2 |
| Gilead Sciences, Inc. | $45.75 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,640.00 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105532874 | CMS |
| Gilead Sciences, Inc. | $45.75 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133795605 | CMS |
| Merck Sharp & Dohme LLC | $18.09 | 11/15/2024 | Education | Undisputed | 01/23/2026 | 1141667474 | CMS |
| PFIZER INC. | $145.14 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131447843 | CMS |
| PFIZER INC. | $1,260.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132040713 | CMS |
| TerSera Therapeutics LLC | $64.59 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144719298 | CMS |
| TerSera Therapeutics LLC | $216.47 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144719300 | CMS |
| TerSera Therapeutics LLC | $368.57 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144719302 | CMS |
| TerSera Therapeutics LLC | $2,000.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144719304 | CMS |
| TerSera Therapeutics LLC | $315.81 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144719306 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.